Longitudinal Data Registry of Plasma Cell Dyscrasia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19-99
SponsorShanghai Zhongshan Hospital
About this trial
This study aims to identify clinical characteristics, response and clinical outcome of plasma cell dyscrasia (PCD) diagnosed in Zhongshan Hospital, Fudan University from May 2023. In its current version, the registry incorporates historical data (collected from 2007) and is prospectively collecting follow-up data and recording patient outcomes.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov